|
[1]
|
Byrne, R.A., Rossello, X., Coughlan, J.J., et al. (2023) 2023 ESC Guidelines for the Management of Acute Coronary Syndromes. European Heart Journal, 44, 3720-3826. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Hu, SS. (2023) Report on Cardiovascular Health and Diseases in China 2021: An Updated Summary. Journal of Geriatric Cardiology, 20, 399-430. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Holmes, F.L. (1968) Lecons sur les Phenomenes de la vie communs aux animaux et aux vegetaux. Claude Bernard, 59, No. 3. [Google Scholar] [CrossRef]
|
|
[4]
|
Dungan, K.M., Braithwaite, S.S. and Preiser, J.C. (2009) Stress Hypergly-caemia. The Lancet, 373, 1798-1807. [Google Scholar] [CrossRef]
|
|
[5]
|
Lemkes, B.A., Hermanides, J., Devries, J.H., et al. (2010) Hyperglycemia: A Prothrombotic Factor? Journal of Thrombosis and Haemostasis, 8, 1663-1669. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Wernly, B., Lichtenauer, M., Franz, M., et al. (2016) Dif-ferential Impact of Hyperglycemia in Critically Ill Patients: Significance in Acute Myocardial Infarction But Not in Sepsis? International Journal of Molecular Sciences, 17, Article 1586. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Wahab, N.N., Cowden, E.A., Pearce, N.J., et al. (2002) Is Blood Glucose an Independent Predictor of Mortality in Acute Myocardial Infarction in the Thrombolytic Era? Journal of the American College of Cardiology, 40, 1748-1754. [Google Scholar] [CrossRef]
|
|
[8]
|
Capes, S.E., Hunt, D., Malmberg, K., et al. (2000) Stress Hyperglycaemia and Increased Risk of Death after Myocardial Infarction in Patients with and without Diabetes: A Systematic Overview. The Lancet, 355, 773-778. [Google Scholar] [CrossRef]
|
|
[9]
|
Mamadjanov, T., Volaklis, K., Heier, M., et al. (2021) Ad-mission Glucose Level and Short-Term Mortality in Older Patients with Acute Myocardial Infarction: Results from the KORA Myocardial Infarction Registry. BMJ Open, 11, e046641. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Ferreira, J.A., Baptista, R.M., Monteiro, S.R., et al. (2021) Admission Hyperglycemia and All-Cause Mortality in Diabetic and Non-Diabetic Patients with Acute Myocardial In-farction: A Tertiary Center Analysis. Internal and Emergency Medicine, 16, 2109-2119. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Stalikas, N., Papazoglou, A.S., Karagiannidis, E., et al. (2022) Association of Stress Induced Hyperglycemia with Angiographic Findings and Clinical Outcomes in Patients with ST-Elevation Myocardial Infarction. Cardiovascular Diabetology, 21, Article No. 140. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Cui, K., Fu, R., Yang, J., et al. (2022) Admission Blood Glucose and 2-Year Mortality after Acute Myocardial Infarction in Patients with Different Glucose Metabolism Status: A Prospective, Nationwide, and Multicenter Registry. Frontiers in Endocrinology, 13, Article 898384. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Wei, Q.C., Chen, Y., Gao, Q.Y., et al. (2023) Association of Stress Hyperglycemia with Clinical Outcomes in Patients with ST-Elevation Myocardial Infarction Undergoing Percu-taneous Coronary Intervention: A Cohort Study. Cardiovascular Diabetology, 22, Article No. 85. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zeller, M., Cottina, Y., Brindisi, C.M., et al. (2004) Impaired Fasting Glucose and Cardiogenic Shock in Patients with Acute Myocardial Infarction. European Heart Journal, 25, 308-312. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Aronson, D., Hammerman, H., Kapeliovich, M.R., et al. (2007) Fasting Glucose in Acute Myocardial Infarction. Diabetes Care, 30, 960-966. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wang, H., Zhang, Y., Shen, Z., et al. (2021) Prognostic Value of Fasting Glucose on the Risk of Heart Failure and Left Ventricular Systolic Dysfunction in Non-Diabetic Patients with ST-Segment Elevation Myocardial Infarction. Frontiers of Medicine, 15, 70-78. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Liao, W.I., Sheu, W.H.H., Chang, W.C., et al. (2013) An Elevated Gap Between Admission and A1C-Derived Average Glucose Levels Is Associated with Adverse Outcomes in Diabetic Patients with Pyogenic Liver Abscess. PLOS ONE, 8, e64476. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Nathan, D.M., Kuenen, J., Borg, R., et al. (2008) Translating the A1C Assay into Estimated Average Glucose Values. Diabetes Care, 31, 1473-1478. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
马瑞聪, 杲建波, 茆诗源, 等. 血糖间隙对急性心肌梗死患者院内主要不良心血管事件的预测价值[J]. 实用临床医药杂志, 2022, 26(3): 29-33, 43.
|
|
[20]
|
Wu, S., Yang, Y., Zhu, J., et al. (2022) Impact of Glycemic Gap on 30-Day Adverse Outcomes in Patients with Acute ST-Segment Elevation Myocardial Infarction. [Google Scholar] [CrossRef]
|
|
[21]
|
Roberts, G.W., Quinn, S.J., Valentine, N., et al. (2015) Relative Hyperglycemia, a Marker of Critical Illness: Introducing the Stress Hyperglycemia Ratio. The Journal of Clinical Endocrinology & Metabolism, 100, 4490-4497. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Xu, W., Yang, Y., Zhu, J., et al. (2022) Predictive Value of the Stress Hyperglycemia Ratio in Patients with Acute ST-Segment Elevation Myocardial Infarction: Insights from a Multi-Center Observational Study. Cardiovascular Diabetology, 21, Article No. 48. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Cui, K., Fu, R., Yang, J., et al. (2023) The Impact of Fasting Stress Hyperglycemia Ratio, Fasting Plasma Glucose and Hemoglobin A1c on In-Hospital Mortality in Patients with and without Diabetes: Findings from the China Acute Myocardial Infarction Registry. Cardiovascular Diabetology, 22, Article No. 165. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Yang, J., et al. (2022) The Impact of the Stress Hyperglycemia Ratio on Short-Term and Long-Term Poor Prognosis in Patients with Acute Coronary Syndrome—Insight from a Large Cohort Study in Asia. Diabetes Care, 45, 947-956.
|
|
[25]
|
Abdu, F.A., Galip, J., Qi, P., et al. (2023) Association of Stress Hyperglycemia Ratio and Poor Long-Term Prognosis in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries. Cardiovascular Diabetology, 22, Article No. 11. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Şimşek, B., Çınar, T., Ozan, V., et al. (2021) The Association of AcutetoChronic Glycemic Ratio with No-Reflow in Patients with STSegment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Kardiologia Polska, 79, 170-178. [Google Scholar] [CrossRef]
|
|
[27]
|
Lin, Z., Liang, X., Zhang, Y., et al. (2023) Positive Association between Stress Hyperglycemia Ratio and Pulmonary Infection in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Cardiovascular Diabetology, 22, Article No. 76. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Sia, C.H., Chan, M.H.H., Zheng, H., et al. (2021) Optimal Glucose, HbA1c, Glucose-HbA1c Ratio and Stress-Hyperglycaemia Ratio Cut-Off Values for Predicting 1-Year Mor-tality in Diabetic and Non-Diabetic Acute Myocardial Infarction Patients. Cardiovascular Diabetology, 20, Article No. 211. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Thorp, A.A. and Schlaich, M.P. (2015) Relevance of Sympa-thetic Nervous System Activation in Obesity and Metabolic Syndrome. Journal of Diabetes Research, 2015, Article ID: 341583. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Tran, H.V., Gore, J.M., Darling, C.E., et al. (2018) Hypergly-cemia and Risk of Ventricular Tachycardia among Patients Hospitalized with Acute Myocardial Infarction. Cardio-vascular Diabetology, 17, Article No. 136. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Paneni, F., Beckman, J.A., Creager, M.A., et al. (2013) Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I. European Heart Journal, 34, 2436-2443. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Meza, C.A., La Favor, J.D., Kim, D.H., et al. (2019) Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS? International Journal of Molecular Sciences, 20, Article 3775. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Yuan, T., Yang, T., Chen, H., et al. (2019) New Insights into Oxidative Stress and Inflammation during Diabetes Mellitus-Accelerated Atherosclerosis. Redox Biology, 20, 247-260. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Oliver Emeritus, M.F. and Opie, L.H. (1994) Effects of Glucose and Fatty Acids on Myocardial Ischaemia and Arrhythmias. The Lancet, 343, 155-158. [Google Scholar] [CrossRef]
|
|
[35]
|
Caturano, A., Galiero, R., Pafundi, P.C., et al. (2021) Does a Strict Glycemic Control during Acute Coronary Syndrome Play a Cardioprotective Effect? Pathophysiology and Clinical Evidence. Diabetes Research and Clinical Practice, 178, Article ID: 108959. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Malmberg, K., Rydén, L., Efendic, S., et al. (1995) Randomized Trial of Insulin-Glucose Infusion Followed by Subcutaneous Insulin Treatment in Diabetic Patients with Acute Myocardial Infarction (DIGAMI Study): Effects on Mortality at 1 Year. Journal of the American College of Cardiology, 26, 57-65. [Google Scholar] [CrossRef]
|
|
[37]
|
Malmberg, K., Ryden, L., Wedel, H., et al. (2005) Intense Metabolic Control by Means of Insulin in Patients with Diabetes Mellitus and Acute Myocardial Infarction (DIGAMI 2): Effects on Mortality and Morbidity. European Heart Journal, 26, 650-661.
|
|
[38]
|
Cheung, N.W., Wong, V.W. and McLean, M. (2006) The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) Study. Diabetes Care, 29, 765-770. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
De Mulder, M., Umans, V.A., Cornel, J.H., et al. (2013) Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome: Results of the Randomized BIOMarker Study to Identify the Acute Risk of a Coronary Syndrome-2 (BIOMArCS-2) Glucose Trial. JAMA Internal Medicine, 173, 1896-1904. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Lee, S.A., Cho, S.J., Jeong, M.H., et al. (2014) Hypo-glycemia at Admission in Patients with Acute Myocardial Infarction Predicts a Higher 30-Day Mortality in Patients with Poorly Controlled Type 2 Diabetes than in Well-Controlled Patients. Diabetes Care, 37, 2366-2373. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Lee, T.F., Burt, M.G., Heilbronn, L.K., et al. (2017) Relative Hypergly-cemia Is Associated with Complications Following an Acute Myocardial Infarction: A Post-Hoc Analysis of HI-5 Data. Cardiovascular Diabetology, 16, Article No. 157. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Marx, N., Federici, M., Schütt, K., et al. (2023) 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. European Heart Journal, 44, 4043-4140. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
American Diabetes Association (2021) 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2021. Diabetes Care, 44, S200-S210. [Google Scholar] [CrossRef]
|
|
[44]
|
Mone, P., Varzideh, F., Jankauskas, S.S., et al. (2022) SGLT2 Inhibition via Empagliflozin Improves Endothelial Function and Reduces Mitochondrial Oxidative Stress: Insights from Frail Hypertensive and Diabetic Patients. Hypertension, 79, 1633-1643. [Google Scholar] [CrossRef]
|
|
[45]
|
Zhu, Y., Zhang, J., Jin, H., et al. (2023) The Ef-fect of SGLT2i on In-Hospital Acute Heart Failure Risk in Acute Myocardial Infarction Patients—A Retrospective Study. Frontiers in Cardiovascular Medicine, 10, Article 1158507. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Roos, S.T., Timmers, L., Biesbroek, P.S., et al. (2016) No Benefit of Additional Treatment with Exenatide in Patients with an Acute Myocardial Infarction. International Journal of Cardiology, 220, 809-814. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Del Olmo García, M.I. and Merino-Torres, J.F. (2020) GLP 1 Receptor Agonists, Glycemic Variability, Oxidative Stress and Acute Coronary Syndrome. Medical Hypotheses, 136, Article ID: 109504. [Google Scholar] [CrossRef] [PubMed]
|